Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial-Reference-Cited by-同舟云学术

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

Published:1999-08 Issue:9179 Volume:354 Page:635-639
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Rembacken BJ,Snelling AM,Hawkey PM,Chalmers DM,Axon ATR

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. Infectious colitis endoscopically simulating inflammatory bowel disease: a prospective evaluation;Tedesco;Gastrointest Endosc,1983

2. Rectal biopsy in patients presenting to an infectious disease unit with diarrhoeal disease;Dickinson;Gut,1979

3. Microbial factors in chronic intestinal inflammation;Sartor;Curr Opin Gastroenterol,1996

4. Intestinal epithelial hyperplasia induced in SCID mice by transfer of coisogenic CD4$^{ + }$/CD45RB$^{hi }$T cells is inhibited by intestinal bacterial decontamination;Morrissey;Clin Immunol Immunopathol,1995

5. Spontaneous colitic C3H/HeJBir mice demonstrate antibody reactivity to isolated clones of enteric bacteria;Brandwein;Gastroenterology,1995

Cited by 966 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Causal role of the gut microbiome in certain human diseases: a narrative review;eGastroenterology;2024-09

2. Prebiotics Ingestion in Relevance to Lactose Intolerance Alleviation;2024-08-10

3. Efficacy and safety of probiotics in IBD: An overview of systematic reviews and updated meta‐analysis of randomized controlled trials;United European Gastroenterology Journal;2024-08-06

4. Potential of using an engineered indole lactic acid producing Escherichia coli Nissle 1917 in a murine model of colitis;Scientific Reports;2024-07-30

5. Importance of Gut Microbiota in Patients with Inflammatory Bowel Disease;Nutrients;2024-06-30